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INTRODUCTION 
Peritoneal carcinomatosis is a major source of morbidity 
and mortality in patients with advanced abdominal 
neoplasms. Intraperitoneal chemotherapy (IPC) is an area of 
intense interest given its efficacy in ovarian cancer. 
However, large peritoneal metastases with adequate blood 
flow have a high interstitial fluid pressure, which inhibits 
intratumoral drug distribution (1). To study drug 
penetration and its influencing factors, reliable in vivo 
models that mimic peritoneal metastases are crucial. 
EXPERIMENTAL METHODS  
Poly-lactic acid scaffolds of 0.1cm3 were coated with gelatin 
and were seeded with combinations of ovarian cancer cells 
(SK-OV-3-Luc-eGFP, 2x106) and cancer-associated 
fibroblasts (CAF, 8x106). Viability of these tumor scaffolds 
was longitudinally monitored by bioluminescent imaging 
(BLI) and assessed by end-point Live/Dead staining. Cancer 
cell-CAF organization in the scaffolds were visualized by 
histology, scanning electronic microscopy (SEM, fig 1A)) 
and confocal microscopy (fig 1B). After 3 weeks of in vitro 
culture, the tumor scaffolds were intraperitoneally 
implanted onto the peritoneal wall. Cancer cell viability 
was monitored by BLI, blood vessel infiltration by µCT and 
tissue formation and organization by histology (fig 1C-E).  
RESULTS AND DISCUSSION  
CAFs (fig 1B red) are organized into spheroids between the pores, whereas cancer cells (fig 1B green) 
grow both on the scaffold struts and also in the aforementioned spheroids. Cancer cells adhered to 
the 3D scaffolds follow the print direction of the struts. After in vivo implantation, tumor scaffolds 
become vascularized (fig 1D) and show exponential growth of cancer cells. Histological analysis reveals 
infiltration of host fibroblasts, inflammatory cells and both small and large pericyte-covered blood 
vessels. All these histological aspects show remarkable similarities to size-comparable peritoneal 
metastases of ovarian cancer patients (fig.1E-F). 
CONCLUSION 
In vitro cultured heterocellular 3D scaffolds become functionalized in vivo by the host. The newly 
formed tissue remarkably biomimics a peritoneal metastasis of an ovarian cancer patient. This model 
opens new opportunities for therapeutic evaluation of drugs against peritoneal metastases (and their 
microenvironment). 
REFERENCE: 1) Koppe M. et al., J. Surg. Oncol. 10:6, 2014  
ACKNOWLEDGMENTS: The authors would like to thank the Research Council of Ghent University for 
providing financial support to this project. 
Fig.1: In vitro SEM (A) and confocal (B) 
images of tumor scaffolds (green: cancer 
cells; red: CAFs). C) a timeline of the in vivo 
experiments. D) Contrast-enhanced μCT 3 
weeks after implantation: TS (tumor 
scaffold), BS (blanc scaffold, no cells) The 
two scaffolds are differently oriented. H&E 
staining of a tumor scaffold 4 weeks after 
implantation (E) and a patient-derived 
ovarian cancer peritoneal metastasis (F). 
Scale bar 200µm.  
